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Introduction
The Coulter DACOS (Discrete Analyser with Continu-
ous Optical Scanning) is a discrete analyser capable of
producing 450 test results/h. It has a repertoire of 28
chemistries, which use small volumes ofboth serum (2 1
to 20 1) and reagents (20 1 to 300 tl). The minimum
volume which can be read by the spectrophotometer is
120 1.
Two independent groups ofworkers in the UK developed
novel prototype analytical systems [1 and 2]. They
sought to incorporate the advantages of centrifugal
analysis [3], such as frequent optical measurements, with
the benefits of sequential continuous analysis. The main
feature of the resulting system is that instead of samples
being spun in a rotor around the light source, the optical
system itself is rotated continuously around the samples.
As a result, the instrument has been developed into a
high-capacity discretionary analyser. It has a greater
throughput and less operator involvement than the
centrifugal analyser, which has generally been used to
handle the work-load in separate batches of tests.
The’DACOS incorporates a minicomputer which is used
for instrument control, reaction monitoring and data
processing. Commercial development of the system has
been carried out by Coulter Electronics Ltd (Northwell
Drive, Luton, Bedfordshire LU3 3RH, UK) and Coulter
Electronics, Inc. (Hialeh, Florida, USA).
Instrument operation
Description
The DACOS is a modular system consisting of the
following units" power supply, system control unit with a
cartridge disk system, analyser, video display terminal
with keyboard and printer.
Test programming is carried out via the keyboard. A
sequence number and details of the tests to be performed
are entered for each specimen. Complete demographic
data may be entered if required. This information is filed
by the central processing unit (CPU) and is linked to the
sample position on a particular tray. The tray, which has
a maximum of 64 sample positions, is loaded into the
DACOS and the analyses are performed. All the tests
requested for any one sample are performed before
moving to the next specimen.
The instrument contains a number of dedicated micro-
processors. These control pipetting, via Hamilton
(Hamilton Bonadurz AG, PO Box 26, CH 7402
Bonadurz, Switzerland) syringes linked to stepping
motors, sample and reagent arm movement, cuvette and
sample disk turntable indexing and operation of the
cuvette wash system.
Instrument functions occur on an 8 s time cycle. The
processes of sample addition, reagent and 2 addition,
spectrophotometry and cuvette washing operate sequen-
tially on each sample within the instrument. Maximum
sample incub.ation time is 12"5 min for a single reagent
test or 9"5 min if a second reagent is to be added.
The plastic cuvettes, which are contained within a
120-place rotor, can be reused and individually replaced.
They have been found to have a life-span of three to four
months in routine use. However, staining by some
reagents can considerably reduce their life-span.
In operation, serum is sampled from a disposable sample
plate. This has 64 patient and 16 ’stat’ wells, each of
which have a maximum volume of 350 1, together with
16 calibrator/control wells, each of which have a maxi-
mum volume of 700 1. The serum is washed into the
cuvette ring with 20 to 200 1 of saline. Mixing is
accomplished by force of addition of the sample and
diluent.
Provided sufficient volume is present (120 tl), a blank
reading may be made on the solution before addition of
the first reagent after 42 s. Mixing is accomplished
afterwards by vibration of the reagent probe within the
cuvette. A blank reading for the combined sample versus
reagent may then be taken. If a second reagent is
required, it can be added and mixed after a further 160 s.
Readings can then be taken every 8 s for up to 12"5 min
with a one-reagent chemistry (92 data points), or for 9"5
min with a two reagent chemistry (71 data points).
After the reaction has been completed, the cuvette is
laundered and its optical cleanliness checked ready for
the next serum addition.
The complete operation on the instrument is computer
controlled by a Texas Instruments (Texas Instruments
Corporation, PO Box 2909, Austin, Texas 78769, USA)
computer; Model 990. Data storage (10 megabytes) is on
cartridge type disks. Five megabytes of-this are in the
form of a removable disk and the system is provided with
a number of disk options; amongst which is a test
definition disk which allows the operator to program the
various test parameters required by the system.
63A. E. Hurrell et al. Evaluation of the DACOS analyser
Calibration
The DACOS can be calibrated by one ofseveral different
methods. Each analyte can use as many as six standards
ofdifferent concentration and each standard point can be
determined by a maximum of three replicates.
The simplest calibration method is for enzyme analysis.
This incorporates a blank, where water is substituted for
sample, to check the performance ofthe reagents. Results
are calculated by means of the appropriate molar
extinction coefficient, which has previously been entered
into memory.
Most of the chemistries are calibrated by using a water
blank and three serum standards. A measure of quality
control is obtained by applying linear regression analysis
to the standard line. This monitors linearity, slope and
intercept. The chi-square test is used to indicate the
variability of the standard points about the computed
line.
More complex analyses, such as EMIT (EMIT Trade
Mark of Syva Company, PO Box 10058, Palo Alto,
California 94303, USA), make use of the maximum six
standards. Their absorbances are plotted by means of a
five-parameter LOGIT curve fitting process.
In practice, the test instrument has been calibrated at the
beginning of each working day by means of the DACAL
calibration system marketed by Coulter. This comprises
three calibrators of 3 ml each. For the sake of economy,
each calibrator is divided into three aliquots of ml after
reconstitution and the aliquots are frozen, one being
thawed for use each day. Comparison of results has
shown that this procedure is satisfactory.
Result calculations
After the operator is satisfied that the instrument is
correctly calibrated, test samples may be run and the
absorbance readings passed through a series of data
processing algorithms.
The tests programmed into the DACOS fit one of the
following four categories:
(1) Linear rate of absorbance change with time (zero
order kinetics).
Table 1. Methods used.
(2) Exponential change ofabsorbance over a fixed time
period (first order kinetics).
(3) Change in absorbance over a fixed interval of time
(initial reaction rate).
(4) Final absorbance when reaction is complete
(equilibrium reaction).
The output from the DACOS is from a Data General
(FACIT, 235 Main Dunstable Road, Nashua, New
Hampshire 03061, USA) printer onto standard listing
paper. The software includes quality-control procedures
and the ability to generate duplicate reports if required.
An RS232-C interface is standard equipment on the
instrument and a bidirectional interface will shortly be
available.
The evaluation
An initial evaluation was carried out over seven days. The
instrument performed close to specification. However,
two particular features were identified as requiring
further investigation: excessive noise and sample-to-
sample interaction.
Subsequently, an evaluation of a variety of methods was
carried out over a three-month period. The guidelines
adopted for the evaluation were taken from those
published by Broughton et al. [4] and the European
Committee for Clinical Laboratory Standards [5].
Materials and methods
Instruments and reagents
The DACOS analyser was purchased from COULTER
Electronics Ltd, as were DART(R reagents for glucose
and uric acid assays, together with DACAL lyophilized
human serum calibrators. For glucose and uric acid tests
the reagents and calibrators were used as directed by the
manufacturer. The remainder of the methods-ALT,
ALP, GGT, CK, LDH (Non-standard abbreviations:
ALT, alanine-amino transferase [EC 2.6.1.1]; ALP,
alkaline phosphatase [EC 3.1.3.1]; GGT, gamma glu-
tamyltransferase [EC 2.3.2.2]; CK, creatine kinase [EC
2.7.3.2]; LDH, lactate dehydrogenase [EC 1.1.1.27])-
used during the evaluation, with the exception of
Analyte
Sample Diluent Reagent
volume volume
(tl) (I)
Volumes
(tl)
2 Supplier Method Catalogue No.
Cholesterol
Glucose (BCL)
Glucose (DART)
Triglyceride
Uric acid (BCL)
Uric acid (DART)
ALAT
ALP
CK
GGT
LDH
2 120 200
3 120 300
4 120 200
2 120 200
4 120 150
6 120
20 80 150
3 20 150
6 40 100
8 40 100
4 20 100
8O
20
20
20
20
20
BCL CHOD/PAP 236691
BCL GOD/PAP 166391
DART Hexokinase
MERK GK/NAD/INT
BCL Uricase/PAP 620994
DART Uricase/PAP
BCL SCE 191345
BCL DGFKC 4i5286/415294
BCL DGFKC/SCE 475742/476769
BCL 3-Carb-4-Nitro 543098/543101
BCL DGFKC 543047/543063
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triglyceride, were based on BCL (Boehringer Corpora-
tion Ltd, Bell Lane, Lewes, East Sussex, UK) kits as
specified in table 1. Triglyceride was measured using
Merck reagents supplied by E. M. Diagnostics (E. M.
Diagnostics, Broom Road, Poole, Dorset, UK). In all
cases these reagents were under-diluted to accommodate
the addition of saline diluent as required by the DACOS
sampling system.
The instruments used for comparison studies were LKB
8600 reaction rate analysers (LKB Instruments Ltd,
South Croydon, Surrey, UK), for the enzymes, Techni-
con AAII analysers for cholesterol, triglyceride and uric
acid (Technicon Instruments Ltd, Basingstoke, Hamp-
shire, UK); and a Beckman Glucose 2 (Beckman-RIIC
Ltd, High Wycombe, Buckinghamshire, UK) analyser
for glucose. The reagents used on the comparative
instruments were of the same origin and composition as
those on the DACOS. The two exceptions to this were
glucose reagent from Beckman and uric acid reagent from
BCL (cat. No. 157104).
Specimens
Over 200 serum specimens which had been submitted for
routine analysis were analysed on the DACOS and the
appropriate comparative instrument for the analytes
requested. The sera were selected to give a spread of
concentrations covering low, medium and high values.
Control sera
M + D QAP Chemistry Controls Levels I and II, Merz
Dade (American Hospital Supply (UK) Ltd, Didcot,
Oxfordshire, UK), BCL Precinorm U, Precipath U,
Precilip EL, and Beckman Decision were used in the
study.
Calibration
The Technicon AAII chemistries were calibrated using
Technicon serum calibrators. The Beckman Glucose 2
analyser was calibrated using the Beckman 150/50
standard supplied with the company’s glucose reagents.
Results
Accuracy
The results from the DACOS were compared with
existing methods by the Deeming method of correlation
[6]. Results are shown in table 2. Quality-control
material was made available.from the National Quality
Control Scheme (Wolfson Research Laboratories, Q.E.
Medical Centre, Birmingham, UK), and table 3 shows a
comparison ofthe results obtained from this and from the
Wellcome (Wellcome Diagnostics, Dartford, Kent, UK)
clinical chemistry control scheme.
Table 2. Correlation with existing methods.
Correlation
Analyte N coefficient Slope Intercept
Cholesterol 100 0"969 1"098 -0"02
Glucose (BCL) 200 0.997 1"003 -0"09
Glucose (DART) 200 0.996 0"969 0"07
Triglyceride 100 0"989 1"065 -0"04
Uric acid (BCL) 200 0"953 0’917 -42"50
Uric acid (DART) 200 0"970 0’952 -32"39
ALAT 200 0"997 1"029 -4"68
ALP 200 0’998 1"076 0"07
CK 199 0"995 1"102 18"31
GGT 200 0"997 1"000 0"85
LDH 199 0"978 1"129 35"91
Table 3. Assessment ofaccuracy. Comparison with known control sera from Wellcome and NQAS schemes.
Mean difference from true
Analyte No. analysed Concentration value
Range Units %
Cholesterol 15 2" 15-5"70 +0"012 +4"59
Glucose (BCL) 15 3.91-12.93 +0"034 +0"45
Glucose (DART) 15 3"91-13.04 -0"040 -0" 17
Triglyceride 6 0’51-1"60 +0"098 + 11"4
Uric acid (BCL) 15 225’0-598"0 -39"9 10"3
Uric acid (DART) 15 225’0-598"0 24" 7"58
ALAT 5 26’5-121’7 -4"88 -8"30
ALP 5 111’0-470"0 + 31.6 + 12"6
CK 4 57"1-530"5 -30"3 -8"74
GGT 4 25" 1-98’0 2" 113 5"69
LDH Insufficient data available
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Table 4. Within-batch precision.
Level Level 2 .Level 3
Analyte Units Mean CV Mean CV Mean CV
Cholesterol mmol/1
Glucose (BCL) mmol/l
Glucose (Dart) mmol/1
Triglyceride mmol/1
Uric acid (BCL) gmol/L
Uric acid (Dart) tmol/L
ALAT IU/I
ALP IU/1
GGT IU/1
CK IU/I
LDH IU/1
2"47 1.1 6’55 1.6 9"90 1.5
2"47 0’9 6"16 1"2 13"95 1.1
2"40 0"8 6"09 0"9 13"86 0’8
0"77 1.5 1"72 1.1 3"27 1"3
144.03 1’2 224"06 1"2 471.08 1’2
162"07 1" 224"02 0"9 500’09 1"2
29"09 2"0 78"07 2’0 104.04 1"6
92"01 3"6 463"07 1"2 876"07 1.1
34’09 3" 90"05 2"5 210"01 1.8
54"06 2"3 187"09 1"2 441"03 0"6
101"01 3’9 177"01 2"2 327"05 2"3
Table 5. Between-batch precision.
Level Level 2 Level 3
Analyte Units Mean CV Mean CV Mean CV
Cholesterol mmol/1
Glucose (BCL) mmol/1
Glucose (Dart) mmol/1
Tryglyceride mmol/1
Uric acid (BCL) mol/1
Uric acid (Dart) gmol/1
ALAT IU/I
ALP IU/1
GGT IU/1
CK IU/1
LDH IU/1
2"63 2’9 6"41 2"1 10"67 2"1
4’63 2"3 6’21 1"9 13"92 1"7
4’54 2"9 6"59 2"7 13"90 2"6
1’01 4’0 1’70 4"7 3’38 5"0
255"3 4’3 433"4 3"5 472"01 3"3
270"3 3’2 456"9 3"2 500"03 3"1
1"3 3"9 52"8 2"1 100"01 2"1
150"2 3’9 454"6 4"3 865"05 1"9
34"4 4"3 66"9 2"5 211"08 1"8
53"1 9"5 145"9 2"6 385"04 6’5
142’9 7’0 316"2 3’6 346"05 3"3
Table 6. Linearity ranges.
Laboratory
Programmed reference
Analyte Unit linearity interval
Cholesterol mmol/1 12"0 less than 7"3
Glucose (BCL) mmol/l 30"0 3"0-5"0
Glucose (Dart) mmol/1 33"0 3.7-5"9
Tryglyceride mmol/1 10"0 less than 1"8
Uric acid (BCL) tmol/1 1200"0 110.0-360"0
Uric acid (Dart) tmol/1 1490"0 140"0-490"0
ALAT IU/1 1000’0 less than 30
ALP IU/1 2500’0 less than 275
GGT IU/1 1000"0 less than 50
CK IU/1 2500"0 less than 170
LDH IU/1 1000"0 less than 22
Precision
The within-batch precision was determined by analysing
20 identical serum samples for the same test consecu-
tively, at three different levels. The results obtained are
summarised in table 4.
The between-batch precision was determined from three
different levels of control sera which were analysed on 20
consecutive working days. The results obtained are
summarized in table 5.
66
Linearity
The ranges obtained from linearity studies are shown in
table 6. Only a very small number of tests were lost as a
result of being over-range; fewer than 1% needed to be
repeated using a diluted serum. The main tests affected in
this way were the enzymes. Since the chemistries may be
defined entirely by the user, taking as many or as few data
points as he requires for each analysis, linearity ranges
can effectively be extended to infinity. However, if very
high linearity limits were defined, this would obviously
result in some loss of sensitivity at low concentrations.
Carry-over
Sample-to-sample: sample cross-contamination [7] was
determined by alternately sampling from Eosin (5% in
water) and distilled water, measuring the resulting
absorbance change in the water. No increase in absor-
bance was found and it was concluded that no sample
cross-contamination could be demonstrated.
The Broughton procedure [7] was used to assess carry-
over between tests" sampling of three specimens with a
high concentration of a particular analyte was followed
by sampling ofthree specimens with a low concentration.
The experiment was repeated 20 times for each of the
analytes under investigation. The carry-over for all the
chemistries was less than 0"5%.A. E. Iturrell et al. Evaluation of the DACOS analyser
Finally, the effect on carry-over of sampling different
volumes was determined [8]. In order to exploit the
versatility of the DACOS and use it in a true random
access mode, it is possible for a test using a high volume of
serum (for example 20 tl) to be followed by a test using a
relatively low volume of serum (for example 3 tl).
A typical experiment involved sampling three acid
phosphatase estimations (20 tl sample volume), from a
serum containing a considerably raised alkaline phos-
phatase, followed by three estimations for alkaline
phosphatase, b l, b2, b3 (sample volume 3 tl) from a
serum containing low activity of that analyte. The
resulting errors were calculated by using the following
formula, which is a modification of that ofBroughton [7]:
bl b3
Sampling error x 100%
a- b3
where b is the first alkaline phosphatase result and b3 is
the last alkaline phosphatase result, a is the mean value,
from five estimations, of the concentration of alkaline
phosphatase in the sample used for acid phosphatase
estimation. This experiment indicated a sampling error of
2"2%. Subsequent modifications by the manufacturer
have reduced this error to 0"8%.
Reagent-to-reagent: It was thought that in a system where
only one reagent probe was used to sample from several
reagent containers, the possibility existed of transferring
reagent from one container to another.
Pipette accuracy
Pipetting accuracy was measured by weighing pipetted
amounts of water at different volume settings. Pipettes
were found to deliver approximately 3% less than the
stated volume. This is not important for the chemistries
where standards and samples are treated alike. It could,
however, affect enzyme results, which are calculated by
means of a factor which includes pipetted volumes. This
error could be corrected b) the insertion ofan additio.nal
factor in the chemistry parameter programming.
Safety
A suspension of B. subtilis var globigii was pipetted from a
sample plate and used as a biological marker. Consider-
able splashing of the top cover of the instrument was
found to occur, which would necessitate decontamination
of the instrument each day with a bacteriocide.
However, air sampling detected no microbiological
contamination, so aerosols do not seem to constitute a
hazard to the operator./
With respect to mechanical safety, it would be possible, if
extremely unlikely, for an operator to trap a finger
beneath the sample, reagent and work-station probes. All
electrical circuitry and components have been sensibly
sited-so that any fluid leaks would not enter into high
voltage areas.
Reagent cross-contamination was determined in a similar
manner to the sample-to-sample cross-contamination, in
that 5% Eosin solution was used as one reagent and was
followed by distilled water as the other. After measuring
the absorbance of the distilled water, the cross-
contamination was found to be approximately one part in
eight million from reagent-container to reagent-
container.
Reagent-to-reagent carry-over in the reaction cuvette was
again determined by the use of Eosin solution [8]. After
allowance for volume and dilution effects, this carry-over
was found to be approximately one part in 8000.
Sample evaporation
Evaporation from the sample plate was assessed in two
ways:
(1) By repeatedly weighing the plate with the filled
sample cups in position, the loss from evaporation was
found to be 0"6% after h, 1"1% after 2 h, 2"0% after
4 h and 5"0% after 8 h.
(2) By repeatedly analysing the samples on the plate for
glucose, the mean apparent increase in their concentra-
tion was found to be 1"2% after h, 2"5% after 2 h,
3"8% after 4 h and 6"5% after 8 h. It was also noted that
the precision of the analyses diminished over this time,
the coefficient of variation increasing from 1"05% at
time zero to 2"18% after 8 h. This suggests that
evaporation had been greater from particular areas of
the sample plate.
Discussion
The purpose of this evaluation was to determine the
analytical performance of the DACOS in a clinical
laboratory. It was assessed as a replacement for the
analytical systems previously used to measure the ana-
lytes selected for evaluation. The work-load averaged 200
patient samples per day, or approximately 500 requested
tests.
Technical performance
Accuracy: all test methods showed an acceptable correla-
tion between the DACOS and existing techniques. The
manufacturer’s values for the Dacal calibrators were used
during the evaluation. Subsequently, recalibration-of
these calibrators was shown to be the cause of the
proportional errors in cholesterol, triglyceride and uric
acid analyses. Since the molecular extinction coefficient
was used to calculate enzyme results, it is postulated that
small methodological.differences or pipetting inaccuracy
caused the proportional errors in these tests.
Precision: the precision data given in tables 4 and .5 show
that the DACOS gave acceptable precision when com-
pared with Tonks criteria [9], for the analytes evaluated
using the stated calibration and control procedures. The
between-batch precision figures for CK, however, were a
source of concern. Minor methodological changes have
subsequently reduced the CV to 3.4% at a level of 220
IU/1 and 2"3% at a level of 355 IU/1 respectively.
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Calibration and start up procedures
There are a number of’states’ in which the DACOS can
be left. These range from ’ready’, when analysis will begin
immediately on request, to ’off’, when approximately 15
min are required for arm/tray alignment etc., before the
’ready’ state is reached. The operator is able to control
the state in which the instrument is left and consequently
the length of time required before analysis can begin.
Laboratory policy and test/reagent stability will dictate
when calibration is required. A procedure of calibrating
the instrument once at the beginning ofeach working day
was adopted. With the tests which were used during the
evaluation, this resulted in the first 30 min or so of each
working day being set aside for calibration. However,
’Stat’ analysis facilities remain available during the
calibration period. Calibration absorbance data is recor-
ded on the system each time a calibration is performed.
This has shown that daily calibration of the enzyme and
some of the chemistry channels, particularly cholesterol,
triglycerides and glucose, appears tobe unnecessary and
could be replaced by weekly calibration. Similarly, it has
shown that the uric acid channel needed to be calibrated
every day.
Maintenance
Maintenance of the DACOS is easily performed. Weekly
and monthly maintenance checks are performed by
laboratory staff and require 30 min and h respectively.
Quarterly maintenance is provided by Coulter and takes
approximately half a working day.
Speed and potential throughput
At first the authors were disappointed to find that the
speed of reporting results was dependent upon the
number of processes being carried out on the DACOS’s
main computer. This meant that if it was carrying out a
high work-load, i.e. test programming, sample analysis
and result output simultaneously, there was a noticeable
slowing of screen response and printed result output.
Recently, however, a further 256K of memory has been
added to the computer system and all functions can be
carried out simultaneously, without any noticeable slow-
ing of the system. The printing of results commences
approximately 16 min after the start of processing.
If the DACOS was to be used as a profiling instrument,
assuming a 12-test profile, 200 samples could be
processed in a working day. This represents a throughput
of 2500 tests per day. However, the maximum number of
samples that could be run if the test to sample ratio was
2:1 would be approximately 500, because of the time
required for sample/test programming and print-out.
This would represent about 1000 tests per day.
Sample and reagent volumes
The small sample volumes required make the instrument
very suitable for analysing paediatric specimens. Analy-
ses typically use 4 tl of sample. It was found experimen-
tally that there was a dead volume of40 1 in the specimen
cup, but this can be adjusted to as little as 25 1. Reagent
volumes are also economical and average 100-150 1.
However, reagents which are supplied by companies
Sample and reagent volumes
The small sample volumes required make the instrument
very suitable for analysing paediatric specimens. Analy-
ses typically use 4 1 of sample. It was found experimen-
tdlly that there was a dead volume of401 in the specimen
cup, but this can be adjusted to as little as 25 1. Reagent
volumes are also economical and average 100-150 1.
However, reagents which are supplied by companies
other than Coulter had to be diluted rather less than
usual, in order to account for the addition of the saline
diluent during analysis. A sample blank requires the
addition of 120 1 of saline. During the preliminary
evaluation it was found that certain ofthe Coulter DART
reagents were packaged inappropriately. This applied
particularly to albumin and phosphate packs, where the
volume of reagent provided was insufficient to complete
the analysis of a full tray of 64 samples.
Stat analyses
Facilities for emergency assays are extremely good. Any
test provided on the system can be processed as a stat
analysis. Stat requests made during a routine run are
processed as soon as the current specimen has been
sampled for all of its assays. These results are available
approximately 12 min after the test has been started.
Interferences
The effect of possible interferences was tested by analy-
sing serum with and without added haemoglobin, lipid
turbidity and bilirubin. No serious alteration of the
results was noted for any ofthe analytes under evaluation.
It is therefore concluded that the ability ofthe DACOS to
perform a sample blank correction on every sample
processed avoids interference effects.
Computing
The DACOS can be equipped with a standard RS232C
interface, but only unidirectional (instrument-to-host)
communication is available at present. Coulter will be
introducing a bidirectional interface in the near future;
this was recommended in the DHSS evaluation carried
out by Levin et al. 10].
Staffingtraining
The introduction of the DACOS has released one
operator for other duties. Staff have found it easy to use
and need only two or three days’ training to become
proficient at operating the system.
Limitations
Carry-over: both during the preliminary evaluation and
subsequently during the main evaluation, sample-to-
sample interaction was shown to be a problem with the
DACOS. The figure of2"2% interaction, produced in the
differential volume experiment, was considered to be
excessive. However, Coulter have now introduced a
modification which washes the sample probe with far
more saline diluent between samples. Repeating the
differential volume experiment has produced a value for
sample interaction of 0"8%, which is acceptable for
clinical purposes.
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Noise: emission of noise was considered to be excessive
during the preliminary evaluation, but a modification to
the cuvette wash system has reduced this to an acceptable
level, with no appreciable drop in analytical .perform-
ance.
Water: the system uses approximately 11"2 of type 2
deionized water/running hour. This could be considered
to be a limitation. However, it is far more cost effective to
launder semi-disposable cuvettes than to purchase dispo-
sable plastic cuvettes.
Reliability: several persistent problems during the evalua-
tion were encountered, which, although they were
corrected extremely quickly and efficiently by Coulter,
nevertheless gave rise to some concern about the instru-
ment’s long-term reliability. Most ofthese problems were
of a mechanical nature and could well have been caused
by the installation of a DACOS unit which had received
no checking, following its shipment from the USA. In
response to these problems, Coulter now have a policy of
checking each unit for up to a month before delivering it
to the customer. There were a number of intractable
problems related to limitations of the software. The
version II software should be specified for all future
purchases of the DACOS instrument.
Electrolyte capability: direct reading sodium and potassium
ion selective electrodes are now available for the DACOS,
but were not available in time for the evaluation.
Sample and reagent volumes: there are only six pre-set sample
volumes available on the DACOS. Similar restrictions
apply to reagent volumes, but this has presented few
problems in adapting methodologies for use on the
instrument.
Conclusion
The specification and performance of the DACOS is
impressive, although the authors have reservations about
the instrument’s reliability. Analytical results have been
consistently accurate and precise, while operator produc-
tivity has increased. The introduction of a continuous
discrete analysis system in place of methods of batch
analysis has resulted in the laboratory providing a better
service to the clinicians. Turn-around times on the
analyses involved have been reduced by approximately
half. Sample throughput is excellent with the DACOS
and would satisfy the requirements of most small- to
medium-sized district general hospitals. It could also be
useful for removing the more expensive assays, such as
enzymes, from the test profile provided by larger labora-
tories. With the introduction of electrolyte analyses,
bidirectional interfacing and software revisions, the
instrument could be considered as a replacement for
traditional profiling techniques.
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Addendum
Since completing the evaluation we have had the
opportunity to try a new version of the software (1.3.5).
This. cured many of the reliability problems that we had
encountered. However, we then tried using the electrolyte
(I.S.E.) unit and, when this was added to the existing
system, a number of new computer-orientated problems
arose. This finding supports our earlier conclusion that
the computer software for the DACOS needs further
development and evaluation.
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